Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study.

Talanta - 15 Aug 2021

Gomez-Martinez Julien, Foulongne Vincent, Laureillard Didier, Nagot Nicolas, Montès Brigitte, Cantaloube Jean-François, Van de Perre Philippe, Fournier-Wirth Chantal, Molès Jean-Pierre, Brès Jean-Charles

Abstract excerpt

Human immunodeficiency virus (HIV) infection is a chronic disease that can be treated with antiretroviral (ARV) therapy. However, the success of this treatment has been jeopardized by the emergence of HIV infections resistant to ARV drugs. In low-to middle-income countries (LMICs), where transmission of resistant viruses has increased over the past decade, there is an urgent need to improve access to HIV drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Infections

Share to Mutation

Share to Point-of-Care Systems

Source

Identifiers

PMID: 33965042
DOI: 10.1016/j.talanta.2021.122378

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study.PMID 33965042Read ↗

Rapid, low-cost, and portable molecular detection of HIV-1 subtype B and HCV 1a directly from blood.Semantic proximity Read ↗

Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug ResistanceSemantic proximity Read ↗

Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.Semantic proximity Read ↗

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.Semantic proximity Read ↗

Portable Nanopore sequencing solution for next-generation HIV drug resistance testing.Semantic proximity Read ↗

Future technologies for monitoring HIV drug resistance and cureSemantic proximity Read ↗

Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance.Semantic proximity Read ↗

Genetic Variability of HIV-1 for Drug Resistance Assay Development.Semantic proximity Read ↗

HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies.Semantic proximity Read ↗

Attomolar Detection of HIV-1 with Label-Free RCA-rCRISPR on SmartphoneSemantic proximity Read ↗

The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillance.Semantic proximity Read ↗

HIV-PULSE: a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.